Thank you for sharing!

Your article was successfully shared with the contacts you provided.

Biotechnology company Avigen Inc. is close to completing the expansion of its Alameda, Calif. Headquarters.

The company is developing two manufacturing and development facilities that will add just over 22,000 sf to its complex.

The firm said this week it has all but finished its 10,300-sf manufacturing center. The building incorporates robotics technology and is designed for the production of gene therapy products. Avigen plans to finish its second building, a 12,000-sf process development facility, in November.

The company reported increased losses of $15 million in Q2 due to less grant funding, but has raised $75 million in private funding during fiscal 2000.

Want to continue reading?
Become a Free ALM Digital Reader.

Once you are an ALM digital member, you’ll receive:

  • Unlimited access to GlobeSt and other free ALM publications
  • Access to 15 years of GlobeSt archives
  • Your choice of GlobeSt digital newsletters and over 70 others from popular sister publications
  • 1 free article* every 30 days across the ALM subscription network
  • Exclusive discounts on ALM events and publications

*May exclude premium content
Already have an account?



Join GlobeSt

Don't miss crucial news and insights you need to make informed commercial real estate decisions. Join GlobeSt.com now!

  • Free unlimited access to GlobeSt.com's trusted and independent team of experts who provide commercial real estate owners, investors, developers, brokers and finance professionals with comprehensive coverage, analysis and best practices necessary to innovate and build business.
  • Exclusive discounts on ALM and GlobeSt events.
  • Access to other award-winning ALM websites including ThinkAdvisor.com and Law.com.

Already have an account? Sign In Now
Join GlobeSt
Live Chat

Copyright © 2021 ALM Media Properties, LLC. All Rights Reserved.